Empresa BioPlus Acquisition Corp. Nasdaq
Acciones
BIOSU
KYG112171098
Holding Companies
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ross Haghighat
CEO | Chief Executive Officer | 60 | - |
Corporate Officer/Principal | 53 | - | |
Steven Fletcher
PRN | Corporate Officer/Principal | 56 | - |
Alex Serge Vieux
PRN | Corporate Officer/Principal | 66 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01/12/21 |
Jonathan Rigby
CHM | Chairman | 56 | 01/07/21 |
Louis Lange
BRD | Director/Board Member | 72 | 01/12/21 |
Ronald Eastman
BRD | Director/Board Member | 71 | 01/12/21 |
Ross Haghighat
CEO | Chief Executive Officer | 60 | - |
Shawn Cross
BRD | Director/Board Member | 56 | 01/12/21 |
Glen Giovannetti
BRD | Director/Board Member | 61 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 5 750 000 | 0 | 0 | 29,61 % |
Acción B | 1 | 19 367 477 | 7 437 478 ( 38,40 %) | 0 |
Información de la empresa
BioPlus Acquisition Corp.
260 Madison Avenue Suite 800
10016, New York
+
Varia. 1 de ene. | Capi. | |
---|---|---|
+173,89 % | 6552,06 M | |
+2,29 % | 983 M | |
+5,57 % | 1049,06 M | |
+41,91 % | 872 M | |
+20,36 % | 786 M | |
+1,72 % | 664 M | |
-.--% | 600 M | |
-2,15 % | 593 M | |
+40,25 % | 639 M |